Latest
Amgen licenses cancer drug to NatPharma
Amgen has licensed an experimental cancer drug to a Chicago biotech company founded and controlled by billionaire Patrick Soon-Shiong. NatPharma LLC is licensing the rights to AMG 337 from Thousand Oaks-based Amgen to develop and sell AMG 337. The drug is an experimental, phase-two cancer treatment. The licensing agreement is the second between Amgen and Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
